STERIS STE is suffering due to weak cost-reduction initiatives and a tough competitive landscape. Dental sales continue to remain dull. The stock carries a Zacks Rank #4 (Sell). STERIS’ dull Dental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback